匹多莫德联合维生素AD治疗小儿反复呼吸道感染的效果观察

Chinese Pediatrics of Integrated Traditional and Western Medicine ›› 2021, Vol. 13 ›› Issue (5): 421-424.

Effect of pidotimod combined with vitamin AD on children with recurrent respiratory tract infection

Objective:To explore the effect of pidotimod combined with vitamin AD in the treatment of recurrent respiratory tract infection in children.#br# Methods:Totally 195 cases of recurrent respiratory tract infection in children treated in our hospital from February 2018 to August 2019 were selected, and they were divided into 3 groups: pidotimod group(A), vitamin AD group(B), and combination group(C). Group A(65 children) were treated with pidotimod, group B(65 children) were treated with vitamin AD, and group C(65 children) were treated with pidotimod combined with vitamin AD. The total effective rate, immune function index, the relief time of clinical symptoms and the average times of recurrence during the one-year follow-up were compared among the three groups.#br# Results:The total effective rate in group C(98.46%,64/65) was significantly higher than that in group A(87.69%, 57/65) and group B(86.1%,56/65), the difference being statistically significant(P<0.017). The time of fever relief, the of cough relief, the time of disappearance of lung rales and the time of subsiding of tonsil enlargement in group C　ｗｅｒｅ　ｓｉｇｎｉｆｉｃａｎｔｌｙ　ｓｈｏｒｔｅｒ　ｔｈａｎ　ｔｈｏｓｅ　ｉｎ　ｇｒｏｕｐ　Ａ　ａｎｄ　ｇｒｏｕｐ　B(P<0.05). The level of IgA, IgM and IgG in group C ｗａｓ　ｈｉｇｈｅｒ　ｔｈａｎ　ｔｈａｔ　ｉｎ　ｇｒｏｕｐＡａｎｄＢ（P<０．０５）．　Ｔｈｅｒｅ　ｗｅｒｅ　ｎｏ　ｓｅｖｅｒｅ　ａｄｖｅｒｓｅ　ｒｅａｃｔｉｏｎｓ　ｉｎ　ｔｈｅ　ｔｈｒｅｅ　ｇｒｏｕｐｓ．　Ｉｎ　ｔｈｅ　ｏｎｅ-ｙｅａｒ　ｆｏｌｌoｗ-ｕｐ，　ｔｈｅ　ｒｅｃｕｒｒｅｎｃｅ　ｔｉｍｅｓ　ｏｆ　ｕｐｐｅｒ　ａｎｄ　ｌｏｗｅｒ　ｒｅｓｐｉｒａｔｏｒｙ　ｔｒａｃｔ　ｉｎｆｅｃｔｉｏｎ　ｉｎ　ｇｒｏｕｐ　Ｃ　ｗｅｒｅ　ｌｏｗｅｒ　ｔｈａｎ　ｔｈｏｓｅ　ｉｎ　ｇｒｏｕｐ　Ａ　ａｎｄ　Ｂ（P<０．０５）．#br# Conclusion:Ｔｈｅ　ｅｆｆｅｃｔ　ｏｆ　ｐｉｄｏｔｉｍｏｄ　ｃｏｍｂｉｎｅｄ　ｗｉｔｈ　vｉｔａｍｉｎ　ＡＤ　ｄｒｏｐｓ　ｉｓ　ｅｆｆｅｃｔｉｖｅ　ｉｎ　ｔｈｅ　ｔｒｅａｔｍｅｎｔ　ｏｆ　ｃｈｉｌｄｒｅｎ　ｗｉｔｈ　ｒｅｃｕｒｒｅｎｔ　ｒｅsｐｉｒａｔｏｒｙ　ｔｒａｃｔ　ｉｎｆｅｃｔｉｏｎ，　ｗｈｉｃｈ　ｃａｎ　ｉｍｐｒｏｖｅ　ｔｈｅ　ｉｍｍｕｎｅ　ｆｕｎｃｔｉｏｎ，　ｐｒｏｍｏｔｅ　ｔｈｅ　ｒｅｌｉeｆ　ｏｆ　ｃｌｉｎｉｃａｌ　ｓｙｍｐｔｏｍｓ　ａｎｄ　ｒｅｄｕｃｅ　ｔｈｅ　ｒｅｃｕｒｒｅｎｃｅ　ｒａｔｅ　ｏｆ　ｔｈｅ　ｉｎｆｅｃｔｉｏｎ，　ｓｏ　ｉｔ　ｉｓ　ｗｏｒｔｈ　ｐｒｏｍｏｔｉｎｇ．

Liaoning Provincial People's Hospital，Shenyang 110000，China

Online:2021-10-25 Published:2021-12-06

Abstract

Abstract: Objective:To explore the effect of pidotimod combined with vitamin AD in the treatment of recurrent respiratory tract infection in children.
Methods:Totally 195 cases of recurrent respiratory tract infection in children treated in our hospital from February 2018 to August 2019 were selected, and they were divided into 3 groups: pidotimod group(A), vitamin AD group(B), and combination group(C). Group A(65 children) were treated with pidotimod, group B(65 children) were treated with vitamin AD, and group C(65 children) were treated with pidotimod combined with vitamin AD. The total effective rate, immune function index, the relief time of clinical symptoms and the average times of recurrence during the one-year follow-up were compared among the three groups.
Results:The total effective rate in group C(98.46%,64/65) was significantly higher than that in group A(87.69%, 57/65) and group B(86.1%,56/65), the difference being statistically significant(P<0.017). The time of fever relief, the of cough relief, the time of disappearance of lung rales and the time of subsiding of tonsil enlargement in group C　ｗｅｒｅ　ｓｉｇｎｉｆｉｃａｎｔｌｙ　ｓｈｏｒｔｅｒ　ｔｈａｎ　ｔｈｏｓｅ　ｉｎ　ｇｒｏｕｐ　Ａ　ａｎｄ　ｇｒｏｕｐ　B(P<0.05). The level of IgA, IgM and IgG in group C ｗａｓ　ｈｉｇｈｅｒ　ｔｈａｎ　ｔｈａｔ　ｉｎ　ｇｒｏｕｐＡａｎｄＢ（P<０．０５）．　Ｔｈｅｒｅ　ｗｅｒｅ　ｎｏ　ｓｅｖｅｒｅ　ａｄｖｅｒｓｅ　ｒｅａｃｔｉｏｎｓ　ｉｎ　ｔｈｅ　ｔｈｒｅｅ　ｇｒｏｕｐｓ．　Ｉｎ　ｔｈｅ　ｏｎｅ-ｙｅａｒ　ｆｏｌｌoｗ-ｕｐ，　ｔｈｅ　ｒｅｃｕｒｒｅｎｃｅ　ｔｉｍｅｓ　ｏｆ　ｕｐｐｅｒ　ａｎｄ　ｌｏｗｅｒ　ｒｅｓｐｉｒａｔｏｒｙ　ｔｒａｃｔ　ｉｎｆｅｃｔｉｏｎ　ｉｎ　ｇｒｏｕｐ　Ｃ　ｗｅｒｅ　ｌｏｗｅｒ　ｔｈａｎ　ｔｈｏｓｅ　ｉｎ　ｇｒｏｕｐ　Ａ　ａｎｄ　Ｂ（P<０．０５）．
Conclusion:Ｔｈｅ　ｅｆｆｅｃｔ　ｏｆ　ｐｉｄｏｔｉｍｏｄ　ｃｏｍｂｉｎｅｄ　ｗｉｔｈ　vｉｔａｍｉｎ　ＡＤ　ｄｒｏｐｓ　ｉｓ　ｅｆｆｅｃｔｉｖｅ　ｉｎ　ｔｈｅ　ｔｒｅａｔｍｅｎｔ　ｏｆ　ｃｈｉｌｄｒｅｎ　ｗｉｔｈ　ｒｅｃｕｒｒｅｎｔ　ｒｅsｐｉｒａｔｏｒｙ　ｔｒａｃｔ　ｉｎｆｅｃｔｉｏｎ，　ｗｈｉｃｈ　ｃａｎ　ｉｍｐｒｏｖｅ　ｔｈｅ　ｉｍｍｕｎｅ　ｆｕｎｃｔｉｏｎ，　ｐｒｏｍｏｔｅ　ｔｈｅ　ｒｅｌｉeｆ　ｏｆ　ｃｌｉｎｉｃａｌ　ｓｙｍｐｔｏｍｓ　ａｎｄ　ｒｅｄｕｃｅ　ｔｈｅ　ｒｅｃｕｒｒｅｎｃｅ　ｒａｔｅ　ｏｆ　ｔｈｅ　ｉｎｆｅｃｔｉｏｎ，　ｓｏ　ｉｔ　ｉｓ　ｗｏｒｔｈ　ｐｒｏｍｏｔｉｎｇ．

Key words: Recurrent respiratory tract infection, Pidotimod, Vitamin AD, Immune function, Children

XU Sha. Effect of pidotimod combined with vitamin AD on children with recurrent respiratory tract infection[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(5): 421-424.

[1]	LUO Lan, LIU Pingping, FANG Sisi. Study on resting energy expenditure of children with sepsis at acute stage [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(5): 405-408.
[2]	WANG Chunfeng. Effects of immune EN combined with SPN on immune function and prognosis of children with severe viral encephalitis under the management of individualized nutrition support [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(5): 409-412.
[3]	TANG Xiaoli, DENG Hongbo. Retrospective analysis of the clinical characteristics of 23 children with pertussis [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(5): 416-420.
[4]	XIE Ying. Retrospective investigation of risk factors in hospitalized children with recurrent respiratory tract infection [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(5): 425-.
[5]	ZHANG Junqing, GUO Liang, SHI Cannan, WANG Jun. Changes and prediction analysis of the mortality of infants and children under 5 years old in Henan Province [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(5): 428-.
[6]	DU Linlin, WANG Yonghong, HE Jingwei. Study on the medication rules for cough in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(5): 431-.
[7]	DU Fuli, DAI Xiaoyu, ZHENG Yapei, ZHENG Hong. Discussion on the treatment of children's short stature based on time medicine of traditional Chinese medicine [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(5): 454-.
[8]	WANG Shengnan, WANG Guojie, WANG Hai. Observation on the effect of Weijing Ditan decoction in the treatment of children with protracted bacterial bronchitis [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(4): 281-.
[9]	HAN Jing, XU Yan, SUN Liping. Research progress in clinical application of Huaiqihuang granules in pediatrics [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(4): 292-.
[10]	YUAN Jianzai, ZHANG Li, YUAN Yehong, MA Shuxia. Advances in research on the treatment for upper airway cough syndrome based on TCM syndrome differentiation [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(4): 301-.
[11]	LI Yi, SHEN Zhaobo, HUA Li. Observation on the efficacy of dust mite drops combined with terbutaline and montelukast in the treatment of allergic asthma in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(4): 325-.
[12]	LI Peng. Different doses of dexmedetomidineby nasal dripping in surgery for pediatric hernia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(4): 328-.
[13]	SUN Xiangjuan, LIU Li, WENG Dongbo, YU Qiuxiang, ZHANG Fenghua. Effects of modified Jiegeng decoction on children with allergic rhinitis with underlying heat in lung meridian [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(4): 350-.
[14]	WAN Jun, YU Zhou, TAN Yinghui, YANG Zeyi, YANG Xiangzheng. Clinical study of modified Xiaoqinglong decoction in the treatment of children with bronchial asthma of external-coldness and internal-drink type during acute onset [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(4): 353-.
[15]	GAO Xuguang, YANG Meng, ZHANG Maohua, ZHAI Wensheng. Evaluation of therapeutic effect of Yiqi Huayu Qingre decoction on pediatric hormone-sensitive nephrotic syndrome [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2021, 13(4): 358-.

Effect of pidotimod combined with vitamin AD on children with recurrent respiratory tract infection

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments